Educator: Michael Strøm
International speaker & expert in shockwave and EMTT therapy for erectile dysfunction, Peyronie’s disease, and CPPS. Learn more about me
Focus of the Training
The training focused on case studies, roundtable discussions, and instruction from experienced shockwave users. I emphasized the differences between technologies, energy delivery, and practical patient selection rather than presenting a one-size-fits-all protocol. When I teach, the goal is for participants to be able to explain why a particular treatment is chosen, for whom it is appropriate, and when a different approach is more relevant.
Why this is relevant to a patient’s journey
A key point in my teaching is that “shockwave” is not a single, uniform treatment. Electrohydraulic, electromagnetic, and piezoelectric systems produce and deliver energy differently. Therefore, the focus should be on tissue, target, energy, focal zone, and patient selection—not just on the name of the technology or a standard protocol.
That’s also how I want to work at the clinic: first, understand the problem; then, choose the appropriate tests; and finally, decide whether treatment makes sense. This reduces the risk of starting a standard course of treatment based on insufficient evidence.
From Education to Clinical Quality
International education is not, in and of itself, proof of a treatment’s effectiveness. Its value lies in the professional exposure it provides: questions from other practitioners, comparisons of equipment and protocols, discussions of research, and encounters with other patient populations. This forces me to continually distinguish between what is biologically plausible, what has been clinically observed, and what is actually supported by research.
Another important element is managing expectations. In areas such as sexual function, chronic pain, and incontinence, two patients with the same diagnosis may have vastly different causes and prognoses. Therefore, it is important to be precise about which problem is being addressed, how progress is measured, and when a lack of response should lead to a reassessment rather than simply continuing with the same treatment.
I also emphasize the importance of distinguishing between mechanism, clinical evidence, and marketing. The fact that a technology can biologically affect tissue does not mean that it has a documented effect on all indications. Conversely, clinical evidence may be relevant without being directly transferable between different devices, doses, or patient groups. This distinction is crucial both in teaching and in conversations with patients.
For each individual patient, professional expertise should be conveyed with clarity: What do we know? What is likely? What is uncertain? And what is the next rational step? This is the part of the patient journey that is often missing when patients encounter many different treatment options online. My goal is for the examination and explanation to make the choice more manageable before a decision is made about a course of treatment.
It is the professional connection between education and clinical practice that I want these educational activities to demonstrate: not a promise of results, but experience in critically evaluating technology, following the evidence, and translating it into more precise decisions for each individual patient.
Read more: The Evidence for Shockwave Therapy · My Professional Background and MS Insight
Documentation: This article is based on publicly available event materials and/or LinkedIn posts. Sources: LinkedIn posts
Would you like a specialist evaluation of your situation?
You don’t have to figure this out on your own. Call me directly or send a brief message describing your symptoms—I’ll get back to you within 12–24 hours with a concrete recommendation on the next steps.
